Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1997/000995external-prioritypatent/WO1997032873A1/en
Application filed by PfizerfiledCriticalPfizer
Publication of TNSN98033A1publicationCriticalpatent/TNSN98033A1/en
208000037265diseases, disorders, signs and symptomsDiseases0.000abstract1
239000000543intermediateSubstances0.000abstract1
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
L'INVENTION CONCERNE UN COMPOSE PRATIQUEMENT PUR, DE FORMULE (I)...... OU UN DE SES SELS OU PRODUITS DE SOLVATATION PHARMACEUTIQUEMENT ACCEPTABLES. ELLE CONCERNE EGALEMENT UN PROCEDE POUR SA PREPARATION, DES INTERMEDIAIRES UTILISES, AINSI QUE DES COMPOSITIONS LE CONTENANT. APPLICATION : UTILISATION DE CES COMPOSES ET COMPOSITIONS COMME ANTAGONISTES SELECTIFS DES RECEPTEURS DE NMDA DANS LE TRAITEMENT DE DIVERSES MALADIES.THE INVENTION CONCERNS A PRACTICALLY PURE COMPOUND, OF FORMULA (I) ...... OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS OR SOLVATATION PRODUCTS. IT ALSO CONCERNS A PROCESS FOR ITS PREPARATION, INTERMEDIATES USED, AND COMPOSITIONS CONTAINING IT. APPLICATION: USE OF THESE COMPOUNDS AND COMPOSITIONS AS SELECTIVE ANTAGONISTS OF NMDA RECEPTORS IN THE TREATMENT OF VARIOUS DISEASES.
TNTNSN98033A1997-02-271998-02-25
QUINOXALINEDIONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN98033A1
(en)